These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6100236)

  • 1. [Is vasoactive intestinal peptide (VIP) an essential neuropeptide for the heart?].
    Christophe J; Robberecht P
    Bull Mem Acad R Med Belg; 1984; 139(12):527-37. PubMed ID: 6100236
    [No Abstract]   [Full Text] [Related]  

  • 2. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.
    Christophe J; Waelbroeck M; Chatelain P; Robberecht P
    Peptides; 1984; 5(2):341-53. PubMed ID: 6089134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal peptide- and adrenocorticotropin-stimulated adenyl cyclase in cultured adrenal tumor cells: evidence for a specific vasoactive intestinal peptide receptor.
    Birnbaum RS; Alfonzo M; Kowal J
    Endocrinology; 1980 Apr; 106(4):1270-5. PubMed ID: 6244149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
    Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
    J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
    Goursaud S; Pineau N; Becq-Giraudon L; Gressens P; Muller JM; Janet T
    J Neuroimmunol; 2005 Jan; 158(1-2):94-105. PubMed ID: 15589042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of secretin, glucagon and vasoactive intestinal peptide on the hormone-sensitive rat cardiac adenylate cyclase [proceedings].
    Chatelain P; Deschodt-Lanckman M; De Neef P; Christophe J; Robberecht P
    Arch Int Physiol Biochim; 1979 Oct; 87(4):783-4. PubMed ID: 93901
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of vasoactive intestinal peptide, secretin, and related peptides on rat colonic transport and adenylate cyclase activity.
    Waldman DB; Gardner JD; Zfass AM; Makhlouf GM
    Gastroenterology; 1977 Sep; 73(3):518-23. PubMed ID: 892349
    [No Abstract]   [Full Text] [Related]  

  • 9. Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart.
    Sawmiller DR; Henning RJ; Cuevas J; Dehaven WI; Vesely DL
    Neuropeptides; 2004 Oct; 38(5):289-97. PubMed ID: 15464194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PACAP, VIP, and PHI: effects on AC-, PLC-, and PLD-driven signaling systems in the primary glial cell cultures.
    Dejda A; Jozwiak-Bebenista M; Nowak JZ
    Ann N Y Acad Sci; 2006 Jul; 1070():220-5. PubMed ID: 16888170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidation of the vasoactive intestinal peptide pharmacophore for VPAC(2) receptors in human and rat and comparison to the pharmacophore for VPAC(1) receptors.
    Igarashi H; Ito T; Pradhan TK; Mantey SA; Hou W; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2002 Nov; 303(2):445-60. PubMed ID: 12388623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal peptide and neuropeptide modulation of the immune response.
    O'Dorisio MS; Wood CL; O'Dorisio TM
    J Immunol; 1985 Aug; 135(2 Suppl):792s-796s. PubMed ID: 2861233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the cAMP-generating system by vasoactive intestinal polypeptide (VIP) in the human laryngeal malignant cell line HEp-2.
    Prost A; Emami S; Rosselin G; Gespach C
    Biosci Rep; 1984 Dec; 4(12):1045-50. PubMed ID: 6085015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
    Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
    Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
    Nagakawa O; Junicho A; Akashi T; Koizumi K; Matsuda T; Fuse H; Saiki I
    Oncol Rep; 2005 Jun; 13(6):1217-21. PubMed ID: 15870945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting analogue of vasoactive intestinal peptide, [R15, 20, 21, L17]-VIP-GRR (IK312532), protects rat alveolar L2 cells from the cytotoxicity of cigarette smoke.
    Onoue S; Endo K; Ohmori Y; Yamada S; Kimura R; Yajima T; Kashimoto K
    Regul Pept; 2004 Dec; 123(1-3):193-9. PubMed ID: 15518912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide influences neurite outgrowth in cultured rat spinal cord neurons.
    Iwasaki Y; Ikeda K; Ichikawa Y; Igarashi O
    Neurol Res; 2001 Dec; 23(8):851-4. PubMed ID: 11760877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.